Reperfusion Therapy for Acute Myocardial Infarction
- 1 January 1998
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 56 (1) , 31-48
Abstract
Several modes of reperfusion therapy for evolving myocardial infarction (MI) have been developed, which differ in terms of effectiveness, complexity and costs. Reperfusion resources are often...Keywords
This publication has 50 references indexed in Scilit:
- Selection of thrombolytic therapy for individual patients: Development of a clinical modelAmerican Heart Journal, 1997
- Glycoprotein IIb/IIIa Receptor Inhibitors: Putting the EPIC, IMPACT II, RESTORE, and EPILOG Trials into PerspectiveThe American Journal of Cardiology, 1996
- Randomized, double-blind, placebo-controlled dose-ranging study of tirofiban (MK-383) platelet IIb/IIIa blockade in high risk patients undergoing coronary angioplastyJACC, 1996
- A cost-effective analysis of primary coronary angioplasty versus thrombolysis for acute myocardial infarctionThe American Journal of Cardiology, 1995
- Cost Effectiveness of Thrombolytic Therapy with Tissue Plasminogen Activator as Compared with Streptokinase for Acute Myocardial InfarctionNew England Journal of Medicine, 1995
- Individual risk assessment for intracranial haemorrhage during thrombolytic therapyThe Lancet, 1993
- An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- Effect of thrombolytic treatment delay on myocardial infarct sizeThe Lancet, 1992
- Thrombolytic therapy for patients with myocardial infarction presenting after six hoursThe Lancet, 1992
- A Prospective Trial of Intravenous Streptokinase in Acute Myocardial Infarction (I.S.A.M.)New England Journal of Medicine, 1986